Get a Quote
Receive a tailored pricing based on your needs.
- Choose license type
- Multiple user options
- Custom scope & coverage
- Fast turnaround
"Designing Growth Strategies is in our DNA"
The biopreservation market size was valued at USD 4.12 billion in 2025. The market is projected to grow from USD 4.48 billion in 2026 to USD 8.46 billion by 2034, exhibiting a CAGR of 8.3% during the forecast period.
Biopreservation refers to the processes and technologies used to maintain viability, stability, and functional characteristics of biological materials during storage, processing, and transportation. It includes preservation media, cryopreservation solutions, freezing and thawing equipment, storage systems, and handling consumables used for cells, tissues, blood, reproductive samples, and other biospecimens. The market growth is being supported by expansion of cell and gene therapies, increasing biobanking activities, growing biomedical research, development of regenerative medicine, and rising demand for reliable long-term storage of sensitive biological materials.
Furthermore, Thermo Fisher Scientific Inc., PHC Holdings Corporation, Qingdao Haier Biomedical Co., Ltd., Azenta, Inc., and Danaher are among the prominent companies operating in the global market.
Increasing Adoption of Advanced Cryopreservation Technologies for Cell-Based Therapies is a Prominent Market Trend
Development of advanced cryopreservation technologies is emerging as an important trend in the market. Cell and gene therapies contain sensitive living materials that require controlled preservation during manufacturing, storage, transportation, and administration. In addition, manufacturers are focusing on optimized cryoprotectants, standardized freezing and thawing processes, automated handling, and preservation media designed to maintain post-thaw cell viability and functionality.
Download Free sample to learn more about this report.
Rapid Expansion of Cell and Gene Therapy Development to Drive Market Growth
Increasing development and commercialization of cell and gene therapies is a major factor driving the biopreservation market growth. These therapies depend on viable cells and other sensitive biological materials that must retain their functional properties throughout collection, processing, manufacturing, storage, shipment, and clinical administration. In addition, expansion of CAR-T therapies, stem-cell therapies, regenerative medicine, and other advanced therapeutic platforms is consequently increasing demand for specialized preservation media, controlled freezing and thawing technologies, storage systems, and handling consumables.
Market Drivers - Impact & CAGR Contribution (2026–2034)
| Rank | Market Drivers | Overall Impact | CAGR Contribution, 2026–2034 | Impact: 2026-2028 | Impact: 2029-2031 | Impact: 2032-2034 |
|---|---|---|---|---|---|---|
| 1 | Rapid Expansion of Cell & Gene Therapy Development | High | 2.20% | High | High | High |
| 2 | Growing Biobanking and Biospecimen Archiving Activities | High | 1.75% | High | High | High |
| 3 | Increasing Biomedical and Drug Discovery Research | Medium | 1.50% | High | High | High |
| 4 | Rising Adoption of Advanced Cryopreservation Technologies | Medium | 1.35% | Medium | High | High |
| 5 | Growing Demand for Personalized and Regenerative Medicine | Medium | 1.10% | Medium | High | High |
| 6 | Others | Low | 0.65% | Low | Medium | Medium |
| Total Positive Growth Contribution | 8.55% | |||||
Source: Fortune Business Insights
Download Free sample For In-Depth Market Restraints & Risk Analysis
High Cost of Advanced Cryogenic Storage Infrastructure May Limit Adoption
Advanced biopreservation requires specialized freezers, liquid nitrogen storage systems, temperature monitoring, backup systems, validated consumables, and controlled cold-chain infrastructure. Establishing and maintaining these systems can require substantial capital and operating expenditure. Moreover, smaller laboratories, research institutions, hospitals, and biobanks in cost-sensitive markets may therefore face challenges adopting sophisticated storage technologies. Maintenance, energy requirements, monitoring, qualification, and regulatory compliance further increase total operating costs.
Market Restraints - Impact & Negative CAGR Contribution (2026–2034)
| Rank | Market Restraints | Overall Impact | CAGR Contribution, 2026–2034 (2026-2034) |
Impact: 2026-2028 | Impact: 2029-2031 | Impact: 2032-2034 |
|---|---|---|---|---|---|---|
| 1 | High Cost of Advanced Cryogenic Storage Infrastructure | High | -0.11% | High | Medium | Medium |
| 2 | Long replacement cycles and durable product lifespan | Medium | -0.07% | Medium | Medium | Medium |
| 3 | Complex Regulatory and Quality Requirements | Medium | -0.05% | Medium | Medium | Low |
| 4 | Others | Low | -0.02% | Low | Low | Low |
| Total Negative Restraint Contribution | -0.25% | |||||
Source: Fortune Business Insights
Download Free sample For In-Depth Market Restraints & Risk Analysis
Expansion of Personalized Medicine and Biobanking to Create Significant Growth Opportunities
Growing adoption of precision medicine, genomics, translational research, and longitudinal disease studies is increasing the need for high-quality biological sample collections. Biobanks provide researchers with preserved tissues, blood, cells, DNA-related samples, and other biospecimens required for disease research and biomarker development. Expansion of population biobanks and disease-specific repositories can therefore increase demand for long-term cryogenic storage, sample-tracking technologies, and specialized handling systems.
Maintaining Sample Viability and Standardization Across Cold Chain Remains a Major Challenge
Biological materials can be highly sensitive to temperature fluctuations, freeze-thaw cycles, handling conditions, and storage duration. Improper preservation may reduce cell viability, alter biological characteristics, or compromise sample quality. The challenge becomes particularly important for cell therapies and research samples that may need to be transported between collection centers, manufacturing facilities, biobanks, and clinical sites. Furthermore, developing standardized and validated preservation protocols while maintaining sample integrity across the complete cold chain remains a major industry challenge.
Growing Need for Large-Scale Biospecimen Storage to Support Storage Systems Segment Growth
Based on product type, the market is segmented into preservation media & solutions, freezing & thawing systems, storage systems, storage & handling consumables, and others.
The storage systems segment held the largest global biopreservation market share in 2025. This is attributed to increasing volumes of biological samples generated by biobanks, research laboratories, pharmaceutical companies, and cell therapy developers. Moreover, ultra-low-temperature freezers and cryogenic storage systems help maintain cells, tissues, blood, and other biospecimens under controlled conditions for extended periods. Expansion of biobanking and biomedical research infrastructure is increasing storage capacity requirements. Furthermore, growing demand for secure long-term sample preservation is supporting segment growth.
The preservation media & solutions segment is projected to register highest CAGR of 10.2% during the forecast period.
To know how our report can help streamline your business, Speak to Analyst
Growing Collection and Long-Term Storage of Biological Samples to Support Bobanking & Biospecimen Archiving Segment Growth
Based on application, the market is segmented into cell & gene therapy, biobanking & biospecimen archiving, drug discovery & biomedical research, reproductive medicine, and others.
The biobanking & biospecimen archiving segment held the largest market share in 2025. The growth of biobanking & biospecimen archiving segment is attributed to increasing collection and long-term storage of biological samples for clinical research, genomics, precision medicine, and population health studies. Biobanks require controlled preservation environments to maintain sample quality over long periods. Expansion of disease-specific and population-based repositories is increasing demand for storage infrastructure and preservation consumables. Furthermore, increasing utilization of archived biospecimens in drug discovery and biomarker research is supporting segment growth.
The cell & gene therapy segment is projected to register the highest CAGR of 11.1% during the forecast period.
Increasing Preservation of Blood and Stem Cell Samples to Support Blood, Bone Marrow & Cord Blood Segment Growth
Based on sample type, the market is segmented into cell cultures & cell-based products, blood, bone marrow & cord blood, reproductive samples, tissues & tissue constructs, and others.
The blood, bone marrow & cord blood segment held the largest market share in 2025. This segment growth is attributed to the widespread preservation of hematological samples for transplantation, disease research, diagnostic development, and regenerative medicine. Bone marrow and cord blood contain valuable hematopoietic stem cells that require controlled cryogenic preservation for long-term storage. Expansion of stem-cell banking and hematology research is increasing sample volumes. Furthermore, continued utilization of these samples in clinical and research applications is also supporting segment growth.
The cell cultures & cell-based products segment is projected to register highest CAGR of 10.6% during the forecast period.
Expanding Cell and Gene Therapy Pipelines Are Expected to Drive Biopharmaceutical & Cell Therapy Companies Segment Growth
Based on end user, the market is segmented into biopharmaceutical & cell therapy companies, biobanks & biorepositories, academic & research institutes, hospitals & clinical laboratories, and others.
The biopharmaceutical & cell therapy companies segment held the largest market share in 2025. Segment growth is attributed to the increasing development and commercialization of cell and gene therapies, which require reliable preservation of cells, tissues, and biological materials throughout manufacturing and distribution. In addition, growing reliance on cryopreservation media and controlled-rate freezing systems to maintain product viability is expected to support adoption across biopharmaceutical manufacturing settings.
The hospital and clinical laboratories segment is projected to register substantial CAGR of 8.0% during the forecast period.
By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and Middle East & Africa.
North America Biopreservation Market Size, 2025 (USD Billion)
To get more information on the regional analysis of this market, Download Free sample
North America held a dominant share in 2024, valuing at USD 1.52 billion, and also maintained the leading share in 2025, with USD 1.65 billion. The growth of the North American market is attributed to strong biopharmaceutical and biotechnology industries, extensive biomedical research, established biobanking infrastructure, and increasing development of cell and gene therapies.
Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 1.63 billion in 2026, accounting for roughly 36.3% of global sales.
Europe is projected to record a considerable growth rate of 7.1% during the forecast period, and reach a valuation of USD 1.16 billion by 2026. The growth of the European market is attributed to established biomedical research infrastructure, biobanking networks, pharmaceutical and biotechnology industries, and increasing cell therapy research.
The U.K. market in 2026 is estimated at around USD 0.22 billion, representing roughly 5.0% of global revenues.
Germany’s market is projected to reach approximately USD 0.24 billion in 2026, equivalent to around 5.4% of global sales.
Asia Pacific is estimated to hold considerable share in the global market and reach USD 1.13 billion in 2026. The growth of the Asia Pacific market is attributed to increasing biomedical research, expansion of cell and gene therapy development, growing biobanking infrastructure, and rising investment in biotechnology.
The Japan market in 2026 is estimated at around USD 0.26 billion, accounting for roughly 5.8% of global revenues.
China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 0.38 billion, representing roughly 8.4% of global sales.
The India market in 2026 is estimated at around USD 0.13 billion, accounting for roughly 3.0% of global revenues.
The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The growth of Latin America market is attributed to expanding clinical trial activity and biobank establishment, while government-backed genomics initiatives are driving growth in the Middle East & Africa. The Latin America market is set to reach a valuation of USD 0.23 billion in 2026. In the Middle East & Africa, the GCC is set to reach a value of USD 0.07 billion in 2026.
The South Africa market is projected to reach around USD 0.04 billion in 2026, representing roughly 1.0% of global revenues.
Product Innovation and Strategic Expansion to Strengthen Key Player’s Market Position
The biopreservation market has a semi-consolidated competitive structure, comprising prominent players such as Thermo Fisher Scientific Inc., PHC Holdings Corporation, Qingdao Haier Biomedical Co., Ltd., Azenta, Inc., and Danaher. These companies are increasingly focusing on integrated solutions for cell and gene therapy workflows as advanced therapies move from clinical development toward commercial manufacturing.
Other notable players in the global market Eppendorf SE, Merck KGaA, Hamilton Company, Sartorius AG, and Corning Incorporated. These companies are expected to prioritize collaborations to increase their global market share during the forecast period.
The biopreservation market analysis includes a comprehensive study of the market size & forecast by all the market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, as well as key industry developments and investments by key regions. The global market research report also provides a depth competitive landscape with information on the market share and profiles of key operating players.
Request for Customization to gain extensive market insights.
| ATTRIBUTE | DETAILS |
| Study Period | 2021-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2021-2024 |
| Growth Rate | CAGR of 8.3% from 2026-2034 |
| Unit | Value (USD Billion) |
| Segmentation | By Product Type, Application, Sample Type, End User, and Region |
| By Product Type |
|
| By Application |
|
| By Sample Type |
|
| By End User |
|
| By Region |
|
Approach 1: Country-Level Biopreservation Utilization Analysis
Approach 2: Product Volume, Technology Mix & ASP Analysis
Approach 3: End-User Demand Analysis
Approach 1: Manufacturer Revenue & Product Portfolio Analysis
Approach 2: Triangulation, Validation & Forecast Modeling
Supply Side Interviews: 60%
Demand Side Interviews: 40%
According to Fortune Business Insights, the global market value stood at USD 4.12 billion in 2025 and is projected to reach USD 8.46 billion by 2034.
In 2025, the market value stood at USD 1.65 billion.
The market is expected to exhibit a CAGR of 8.3% during the forecast period of 2026-2034.
By product type, the storage systems segment is expected to hold highest share in the market.
Rapid expansion of cell and gene therapy development is drive market growth.
Thermo Fisher Scientific Inc., PHC Holdings Corporation, Qingdao Haier Biomedical Co., Ltd., Azenta, Inc., and Danaher are the major players in the global market.
North America dominated the market in 2025.
Get 30-60 hrs Free Customization
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )
Receive a tailored pricing based on your needs.
Discuss your questions with our industry experts.
Have questions? Get quick answers before you purchase.